HEART RHYTHM DAILY The place to connect withHeart Rhythm attendees.

35TH ANNUAL SCIENTIFIC SESSIONS | MAY 7–10, 2014 | MOSCONE CENTER | SAN FRANCISCO, CA

Heart Rhythm 2014 | 2

MOST WIDELY DISTRIBUTED PUBLICATION AT THE MEETING!

The Friday LaTe-Breaking Clinical Trials session unveiled new devices that could change clinical practice. The biggest change may be a leadless pacemaker implanted in the cardiac wall.

“This device has the potential to bring a paradigm shift in the way we think about pacing,” said Vivek Reddy, MD, Mount Sinai School of Medicine, New York. “The intent of this device is to take the lead out of the picture.”

Dr. Reddy presented “Percutaneous In Vivo Placement of A Novel Intra-cardiac Leadless Pacemaker: Results from The First-in-an Leadless Study.” The new device displaces about one cc. A single-turn helix screws into the myocardium. A docking link locks to a catheter for placement and retrieval via the femoral artery. Battery life is eight to 18 years, depending on pacing use.

The device was successfully placed in 31 of 32 patients across three European centers. Patients were evaluated at two days, three days, six weeks and three months post-implant.

“We conclude that the device is able to be implanted successfully and retrieved successfully,” Dr. Reddy said. “It performed very

much like a standard pacemaker.”The second potential practice-chang-

er is an ablation catheter that senses the force used to push against the en-docardium. Clinicians who maintained the desired pressure during ablation had significantly higher success rates.

“This is one of the first catheters to give us real-time information on the pressure between catheter and tissue,” said lead author Andrea Natale, MD, Texas Cardiac Arrhythmia Institute, Austin, Texas.

Dr. Natale presented “Ablation of Symptomatic Paroxysmal Atrial Fibrillation Using Novel Contact Force Catheter: SMART-AF Trial.” Freedom from recurrence was 71.9 percent overall and 84.4 percent when contact force was within the desired range more than 82 percent of the time.

Wearable DefibrillatorIlan Goldenberg, MD, University of

Rochester Medical Center, Rochester, N.Y., reported “Eighteen Month Results From The Prospective Registry and Follow-up Of Patients Using The Life-vest Wearable Defibrillator (WEARIT-II Registry).” The vest is a bridging strategy for patients waiting

for an ICD or who may need additional evaluation before implantation.

A total of 758 patients enrolled in the registry. The average patient wore a Lifevest 21 hours daily for 80 days.

Sixteen patients had 67 sustained ventricular tachyarrhythmic events, a rate of 40 sustained episodes per 100 person-years. The rates of inappropriate therapy (0.4 percent) and death (0.5 percent) were both low. Forty-two percent of patients received

Greetings! As we conclude another successful Scientific Sessions, I hope that this meeting has fulfilled all of your expectations and that you are leaving armed with new information and best practices that will enhance your work.

I would like to thank Anne M. Gillis, MD, FHRS, Immediate Past President, for a job very well done! She has worked tirelessly and effectively as the president of the Heart Rhythm Society, and we are all very grateful to her.

I cannot imagine a more insightful theme than the one chosen for this year’s Scientific Sessions — “Honoring

Our Past. Shaping Our Future.” I find this message so compelling that I have adopted this theme for my presidency.

The Heart Rhythm Society and the field of electrophysiology can be proud of our past.

Who could have imagined when NASPE was founded that 34 years later many of our members would spend much of their time performing ablation

procedures for atrial fibrillation, implanting devices and routinely ordering genetic tests to help diagnose inherited arrhythmia conditions?

Yet, despite the remarkable past of the Heart Rhythm Society and the field of electrophysiology, we need to be poised to address the challenges that lie

ahead, and in doing so need to be prepared to shape our future.

For instance, health care reform is a reality, and its impact is starting to be felt by the EP community. The “new normal” for which we need to be prepared for includes mandatory reporting of outcomes and payment based on these outcomes. The “new normal” also includes increased cost savings for Medicare. This translates to major reimbursement cuts and bundled codes for electrophysiologists. The Society is working diligently to develop quality measures to ensure that these outcomes are specific for our field and that electrophysiologists

Late-Breaking Clinical Trials Session Introduces New Devices

HRS Plays Key Role in America’s Challenging Health Care Climate, Incoming President Says

I N S I D EExpert Consensus Statement ReleasedHRS, EHRA and APHRS issue guidelines for diagnosing, treating inherited arrhythmia syndromes... Page 2

Passing of the GavelCeremony installs Hugh Calkins, MD, FHRS, as the 35th President of the Heart Rhythm Society... Page 5

PRESidEnt’S LEttER, continued on Page 4

tRiaLS, continued on Page 11

Hugh Calkins, MD, FHRS, CCDS

Daily HigHligHts

34TH ANNUAL SCIENTIFIC SESSIONS MAY 8–11, 2013 | DENVER, COSaturday

Science | Discovery | InnovationHONORING OUR PAST. SHAPING OUR FUTURE.

www.HRSonline.org/ADV

Vivek Reddy, MD

Saturday

7:30 a.m. – noon registration Open

8 – 9:30 a.m. Late-Breaking Clinical Trials Session iii

8 – 9:30 a.m.Preparing For the eP iBhre exam: Challenging Cases and Questions

8 – 9:30 a.m.Preparing For the eP Board exam: Cieds

9:30 a.m. – noonPoster Session (Lobby d)

10:30 a.m. – noonPreparing For the device iBhre exam: Challenging Cases and Questions

10:30 a.m. – noonPreparing For the eP Board exam: intracardiac electrograms, arrhythmia Mechanisms, and Mapping

10:30 a.m. – noonMOC: Self-evaluation Process: 2012 Update in Clinical Cardiac electrophysiology Module B3M Versions 12-1

34TH ANNUAL SCIENTIFIC SESSIONS MAY 8–11, 2013 | DENVER, COWednesday / Thursday

Science | Discovery | InnovationHONORING OUR PAST. SHAPING OUR FUTURE.

www.HRSonline.org/ADV

Wednesday6 a.m. – 7 p.m.Registration Open

7 – 7:45 a.m.Allied Professional Orientation

8 a.m. – 4 p.m.Allied Professionals Forum I, II, & III

8 a.m. – 4 p.m.Basic Science Forum: Heart Rhythm Systems Physiology

3 – 3:30 p.m.Douglas P. Zipes Lectureship Award

8 a.m. – 4 p.m.AF Summit

8:40 – 8:55 a.m.Heart Rhythm Society Founders’ Lectureship Award

8 a.m. – 4 p.m.Lead Management Forum

8 a.m. – 4 p.m.VT/VF Summit

11 a.m. – 3:30 p.m.Hands-On Session

5 – 6 p.m.Opening Plenary

6 – 7:30 p.m.Featured Poster Session and Reception

6 – 7:30 p.m.Exhibit Hall Open

The Heart Rhythm Society has created a new way to provide the cardiac pacing and electrophysiology community the tools needed to navigate the challenges faced daily amid the changing health-care environment.

HRS Consulting Services, which official-ly launched at Heart Rhythm 2013, is an affiliate company of the Heart Rhythm Society. Rod Williams, HRS Consulting Services president, notes that the company will focus on providing expert strategic advisory knowledge relevant to EP labs and clinics looking to strengthen their overall quality of patient care and financial performance.

“Our focus will be very narrow, yet deep, in the electrophysiology space,” Williams said. “We’ll offer a comprehensive insight into policies, payments, practice and patient-care solutions, with a look at EP coding and reimbursement services as well as EP program development assessment and advisory services for the electrophysiology lab.”

HRS Consulting Services is a for-profit company that will help the Society support its ongoing mission to improve the health of patients who suffer from heart rhythm disorders, while enhancing prevention and treatment by supporting research, education and advocacy initiatives. Williams said that the Society would continue

On behalf Of the Scientific SeSSiOnS PrOgram cOmmittee, welcome to Denver and the 34th Annual Scientific Sessions of the Heart Rhythm Society. We have an exciting program ahead of us, with nearly four days packed with reflecting on our historic past and celebrating the advances that are shaping our future.

Every year, heart rhythm professionals — physicians, allied professionals, basic scientists, engineers and our industry partners from more than 70 countries — join us to explore the latest in science, discovery and innovation. Over the next few days, nearly 14,000 of us will take advantage of educational and networking opportunities unmatched anywhere else in the world.

This year, we are celebrating our Society’s evolution, focusing on

“Honoring Our Past. Shaping Our

Future.” As we examine together what’s new and exciting in our field, we will look back at the groundbreaking events that made such advances possible and how what we know today will improve patient care tomorrow.

We are honored to have President Bill Clinton give remarks during the Open-ing Plenary Session. President Clinton served the United States for eight years during a time of unprecedented prosperity and change. He is now a powerful voice for progress around the world as he shares his unique insights and observations with audiences around the world. President Clinton’s public speeches describe the challenges of globalization, emphasizing our growing interdependence, and point the way to-ward a common future based on shared goals and values. President Clinton’s passion for improving lives through

innovation and activism positions him as the perfect complement to our program.

In addition to the exceptional educational sessions offered at Heart Rhythm, a major draw continues to be the vast number of opportunities for networking with colleagues and experts alike. It is our hope that the practical, implementable information you gain here will benefit you, your colleagues back home, and ultimately, heart rhythm disorder patients everywhere.

We have some exciting new additions

WelcOme tO Denver anD the 34th Annual Scientific Sessions of the Heart Rhythm Society! Over the next three-and-a-half days, Heart Rhythm 2013 will showcase the latest science, technology and innovation in our field. Through this meeting we will celebrate our rich history and the pioneers in our field while visioning our future.

This past year as President of the Heart Rhythm Society (HRS), I have had the opportunity to travel around the world networking with members and the global heart rhythm community, forging relationships aimed at achieving our mission of ending death and suffering due to heart rhythm disorders. Partnering with our sister organizations around the world on consensus documents, joint educational programs and public awareness campaigns aimed at improving access and quality of care for patients with heart rhythm disorders remains a strategic priority of HRS. The importance of our Scientific Sessions to the international community is highlighted by an international attendance of more than 40 percent this year. In keeping with our global outreach,

Welcome Message from 2013 Program Chair Richard I. Fogel, MD, FHRS

Science, Discovery and Innovation Continue to Advance Society Letter from HrS PreSident Anne m. GiLLiS, md, fHrS

i n S i d eHRS Past President to Lead new CouncilEric N. Prystowsky, MD, FHRS, will serve as chair for new Development Advisory Council. Page 5

Allied Health Professionals ProgrammingWednesday forums will educate, inspire new and experienced members of this expanding specialty. Page 10

WELCOME, continued on page 15

PRESidEnt’S LEttER, continued on page 14HRS COnSuLting, continued on page 15

Thursday7 a.m. – 6 p.m.Registration Open

8 – 9:30 a.m.Live Case Presentations: Intermountain Medical Center

9:30 a.m. – 5 p.m.Exhibit Hall Open

9:30 – 10:30 a.m.Pioneers Unplugged: Pioneers in Pacing

9:30 a.m. – noonPoster Town and Moderated Poster Sessions

10:30 a.m. – noonLate-Breaking Clinical Trials Session

10:30 a.m. – noonIdeas on Trial: All ICD Leads with Externalized Conductors Should Be Extracted

12:15 – 1:15 p.m.Rapid Fire: Atrial Fibrillation

1:30 – 3:30 p.m.Young Investigator Awards Competition

2 – 5 p.m.Poster Town and Moderated Poster Sessions

3:15 – 4:15 p.m.Pioneers Unplugged: Pioneers in Clinical and Basic Electrophysiology

4:30 – 5:15 p.m.Battle of the Titans: Warfarin is Obsolete

5:30 – 6:15 p.m.Battle of the Titans: Are ICDs Over-Used or Under-Used

Richard I. Fogel, MD, FHRS

HRS ConSulting SeRviCeS to Help ep pRaCtiCeS ReaCH tHeiR goalS

Rod Williams Anne M. Gillis, MD, FHRS

Daily HigHligHts

34TH ANNUAL SCIENTIFIC SESSIONS MAY 8–11, 2013 | DENVER, COFriday

Science | Discovery | InnovationHONORING OUR PAST. SHAPING OUR FUTURE.

www.HRSonline.org/ADV

A History Special Session honoring Gordon K. Moe, MD, PhD, takes place at 12:15 – 1:15 p.m. today in Room 201.

Dr. Moe was the Director of Research of the Masonic Medical Research Labora-tory from 1960-1984. He was involved in the birth of modern cardiac electrophysi-ology and is best known for his studies on the mechanisms of cardiac arrhythmias, particularly atrial fibrillation.

This session will highlight the history of the Gordon K. Moe Laboratory and the

many postdoctoral fellows and scholars who trained at the Masonic Medical Research Laboratory, Utica, N.Y. Partici-pants will learn about Gordon K. Moe, the scientist, the scholar and the warm and caring human being.

Presentations will be chaired by Charles Antzelevitch, PhD, FHRS, director of the Masonic Medical Research Laboratory, Utica, N.Y., and Albert L. Waldo, MD, FHRS, CDDS, of Case Western Research University-University Hospitals.

Current praCtiCe guidelines typically recommend discontinuing oral anticoagulation with warfarin for patients undergoing cardiac proce-dures, but two studies from Thursday’s Late-Breaking Clinical Trials session suggest that patients may do better if warfarin therapy is continued.

Discontinuation of oral warfarin carries a 13-fold risk for periprocedural stroke and hemorrhagic complications following ablation for atrial fibrillation.

“There is an ominous association between atrial fibrillation, ablation and periprocedural stroke,” said Luigi Di Biase, MD, PhD, FHRS, St. David’s Texas Cardiac Arrhythmia Institute, Austin, Texas.

Dr. Di Biase presented “Periproce-dural Stroke and Bleeding Complica-tions in Patients Undergoing Catheter Ablation of Atrial Fibrillation with Different Anticoagulation Manage-ment: Results from The ‘COMPARE’ Randomized Trial.”

A total of 1,584 patients enrolled in the open-label randomized trial before AF ablation. Patients had a CHADs2 score of at least one and were on oral warfarin. Some 790 patients discontin-ued warfarin before ablation and 794 continued. All patients were assessed for neurological bleeding complications

during the 48 hours following ablation.

The off-warfarin group suffered 29 strokes (3.7 percent) and ten TIAs (1.3 percent), a 4.9 percent event rate. The warfarin group had just two strokes (0.25 percent) and no TIAs (p<0.001). Multivariate analysis showed warfarin discon-tinuance as the strongest predictor of periprocedural complications. There was no difference in major bleeds or pericardial effusions between the groups.

Continued warfarin showed similar advantages for patients undergoing continued warfarin with guideline-rec-ommended heparin bridging therapy was stopped early after the safety com-mittee found an 80 percent reduction in clinically significant hematoma in patients who continued warfarin.

David Birnie, MD, University of Ot-tawa Heart Institute, Ottawa, Canada, presented the results of “Pacemaker

and Defibrillator Surgery Without Interruption of Oral Anticoagulation: Results of the Bridge Or Continue Coumadin for Device Surgery Randomized Controlled Trial (Bruise Control).” The trial randomly assigned patients with a CHADs2 risk of two or higher to bridging anticoagulation or continued Coumadin.

“All of the components of the primary endpoint were positive,” Dr. Birnie said. “Implanting devices without stopping Coumadin is clearly better than heparin bridging.”

Late-Breaking Clinical Trials Session Presents Practice-Changing Data

I N S I D EIn Memoriam

Remembering EP pioneers Paul Crawford Gillette, MD, FHRS, and Brian Hoffman, MD… Page 2

Basic/Translational Science ForumThis year’s event takes a closer look at systems physiology approaches to

heart rhythm research and therapy… Page 15

TrIalS, continued on Page 14

Today’s History Special Session Remembers Arrhythmia PioneerGorDoN K. MoE, MD, PhD, aND hIS Laboratory havE a LaStING IMPact oN carDIac ELEctroPhySIoLoGy

Daily HigHligHts

Presentations by former fellows include:

• Jose Jalife, MD, FHRS, University of Michigan, Ann Arbor

• Juan Tamargo, MD, School of Medicine, Complutense University,Madrid, Spain

• Douglas P. Zipes, MD, FHRS, Krannert Institute of Cardiology, Indianapolis, Ind.

• Commentator Berndt Luederitz,MD, PhD, FHRS, University of Bonn, Bonn, Germany.

Friday7:30 a.m. – 6 p.m.Registration Open

8 – 9:30 a.m.Ideas on Trial Session: Left Atrial Appendage Closure is Better than Anticoagulation Therapy for Stroke Prevention in AF

8 – 9:30 a.m.Live Cases: Mayo Clinic

8 – 9:30 a.m.MOC: Self-Evaluation Process: 2011 Update in Clinical Cardiac Electrophysi-ology Module B3L Versions 11-1

9:30 a.m. – 5 p.m.Exhibit Hall Open

9:30 – 10:30 a.m.Pioneers Unplugged: Pioneers in Ablation

9:30 a.m. – noonPoster Session and Moderated Poster Sessions

10:30 a.m. – noonMOC: Self-Evaluation Process: 2012 Update in Clinical Cardiac Electrophysi-ology Module B3M Versions 12-1

12:15 – 1:15 p.m.Rapid Fire: Device

1:30 – 3 p.m.Oral Abstract Sessions

1:30 – 3 p.m.Late-Breaking Clinical Trials Session

2 – 5 p.m.Poster Session and Moderated Poster Sessions

6 – 7:45 p.m.Awards Ceremony and Presidents’ Reception

David Birnie, MD (right), and Sanjiv Narayan, MD, PhD, FHRS, spoke at Thursday’s Late Breaking Clinical Trials news conference.

Gordon K. Moe, MD, PhD

Click to view the 2013Heart Rhythm Daily issues

➥ ➊ ➋ ➌

HEART RHYTHM DAILY The official daily newspaper of Heart Rhythm 2014 has been an attendee favorite for years! Providing attendees with news on the most current convention happenings, industry announcements, and late-breaking science, the Heart Rhythm Daily offers advertisers the most comprehensive attendee exposure, with 21,000 copies distributed over the four days of the meeting.

DeadlinesMarch 28, 2014 – Ad Space/Payment | April 4, 2014 – Ad Materials Due

PUBLICATION DATES QUANTITY DISTRIBUTION METHOD

Issue 1 – Wednesday/Thursday, May 7/8 9,000May 7/8 – Moscone Center handout and distribution racks May 8 – Distribution racks placed in the lobby atthe major meeting hotels

Issue 2 – Friday, May 9 7,000 Major meeting hotel lobbies, Moscone Center handout, and distribution racks

Issue 3 – Saturday, May 10 5,000 Moscone Center handout and distribution racks

SIZE DIMENSIONS B/W 4/C Full page 10 ¼” x 14” $8,975 $10,800Junior page 7 ½” x 10” $8,100 $9,6251/2 page 10 ¼” x 7” or 5” x 14” $6,165 $7,8901/4 page 5” x 7” $3,500 $4,975Showcase Ad 5” x 3 ½” $1,055

Advertising Rates & Dimensions(Rates include placement in all three issues)

*Ads changing out in the Heart Rhythm Daily will be subject to a 10% fee.

DIGITAL VISIBILITYEngage online readers via the digital issues posted to the HRS website and emailed to HRS members. Ads can link to participants’ designated websites. The sites can be product or corporate.

Ad Animation: $600Embedded Video: $1,100Advertisers' Reader Response Tools and Surveys: $800

Heart Rhythm 2014 | 3

COMMAND ATTENTION WITH PREMIUM PLACEMENT

COVER POSITIONSDrive traffic to your booth and leave a lasting impression with one of these premium, four-color, cover positions.Back Cover $15,950 | Inside Front Cover $13,700

FRONT PAGE BANNER WITH FULL-PAGE, FOUR-COLOR ADGet maximum exposure with the front page banner on every issue. This exclusive opportunity includes a full-page, four-color ad placed run of book. $19,300 for all three issues

BELLYBANDWITH FULL-PAGE, FOUR-COLOR AD IN ALL ISSUESDeliver the first message readers see! Your message wraps around one issue of the Heart Rhythm Daily newspaper, providing can’t-miss visibility. (Advertiser provides printed bellybands)$14,000 per issue

EXHIBIT HALL MAP ADVERTISINGMake your presence on the show floor stand out by highlighting your booth on the Exhibit Hall map printed in each issue of Heart Rhythm Daily. This unique opportunity includes a banner ad on the map page, a box around your exhibitor listing, and a full-page, four-color ad adjacent to the map section.$15,450 for all three issues

CUSTOM INSERTSEnsure that your message jumps out from the pages of the newspaper with a custom insert. You can highlight your company’s products or services on the insert, which cannot exceed 10” x 7”. Advertiser provides printed inserts. $11,895 per issue

Specifications for Premium PositionsPREMIUMS DIMENSIONSCover Positions 10 ¼” x 14”Front Page Banner 10 ¼” x 2”Bellyband 26” x 2 ½”Map Banner 21” x 2”Inserts 10” x 7” (maximum)Distribution Racks Specs provided at space commitment

The Friday LaTe-Breaking

Clinical Trials session unveiled

new devices that could change

clinical practice. The biggest change

may be a leadless pacemaker

implanted in the cardiac wall.

“This device has the potential to

bring a paradigm shift in the way we

think about pacing,” said Vivek Reddy,

MD, Mount Sinai School of Medicine,

New York. “The intent of this device

is to take the lead out of the picture.”

Dr. Reddy presented “Percutaneous

In Vivo Placement of A Novel Intra-

cardiac Leadless Pacemaker: Results

from The First-in-an Leadless Study.”

The new device displaces about one

cc. A single-turn helix screws into the

myocardium. A docking link locks to a

catheter for placement and retrieval via

the femoral artery. Battery life is eight

to 18 years, depending on pacing use.

The device was successfully placed in

31 of 32 patients across three European

centers. Patients were evaluated at

two days, three days, six weeks

and three months post-implant.

“We conclude that the device is

able to be implanted successfully

and retrieved successfully,” Dr.

Reddy said. “It performed very

much like a standard pacemaker.”

The second potential practice-chang-

er is an ablation catheter that senses

the force used to push against the en-

docardium. Clinicians who maintained

the desired pressure during ablation

had significantly higher success rates.

“This is one of the first catheters

to give us real-time information

on the pressure between catheter

and tissue,” said lead author

Andrea Natale, MD, Texas Cardiac

Arrhythmia Institute, Austin, Texas.

Dr. Natale presented “Ablation

of Symptomatic Paroxysmal Atrial

Fibrillation Using Novel Contact Force

Catheter: SMART-AF Trial.” Freedom

from recurrence was 71.9 percent

overall and 84.4 percent when contact

force was within the desired range

more than 82 percent of the time.

Wearable Defibrillator

Ilan Goldenberg, MD, University of

Rochester Medical Center, Rochester,

N.Y., reported “Eighteen Month Results

From The Prospective Registry and

Follow-up Of Patients Using The Life-

vest Wearable Defibrillator (WEARIT-II

Registry).” The vest is a bridging

strategy for patients waiting

for an ICD or who may need additional

evaluation before implantation.

A total of 758 patients enrolled in

the registry. The average patient wore

a Lifevest 21 hours daily for 80 days.

Sixteen patients had 67 sustained

ventricular tachyarrhythmic events,

a rate of 40 sustained episodes

per 100 person-years. The rates of

inappropriate therapy (0.4 percent)

and death (0.5 percent) were both low.

Forty-two percent of patients received

Greetings! As we conclude another

successful Scientific Sessions, I

hope that this meeting has fulfilled

all of your expectations and that

you are leaving armed with new

information and best practices

that will enhance your work.

I would like to thank Anne M. Gillis,

MD, FHRS, Immediate Past President,

for a job very well done! She has

worked tirelessly and effectively as the

president of the Heart Rhythm Society,

and we are all very grateful to her.

I cannot imagine a more insightful

theme than the one chosen for this

year’s Scientific Sessions — “Honoring

Our Past. Shaping

Our Future.” I find

this message so

compelling that I have

adopted this theme

for my presidency.

The Heart Rhythm

Society and the field of

electrophysiology can

be proud of our past.

Who could have

imagined when NASPE

was founded that

34 years later many

of our members would spend much

of their time performing ablation

procedures for atrial

fibrillation, implanting

devices and routinely

ordering genetic tests to

help diagnose inherited

arrhythmia conditions?

Yet, despite the

remarkable past of

the Heart Rhythm

Society and the field

of electrophysiology,

we need to be poised

to address the

challenges that lie

ahead, and in doing so need to be

prepared to shape our future.

For instance, health care reform

is a reality, and its impact is starting

to be felt by the EP community. The

“new normal” for which we need to

be prepared for includes mandatory

reporting of outcomes and payment

based on these outcomes. The “new

normal” also includes increased cost

savings for Medicare. This translates

to major reimbursement cuts and

bundled codes for electrophysiologists.

The Society is working diligently to

develop quality measures to ensure

that these outcomes are specific for

our field and that electrophysiologists

Late-Breaking Clinical Trials Session

Introduces New Devices

HRS Plays Key Role in America’s Challenging

Health Care Climate, Incoming President Says

I N S I D EExpert Consensus Statement Released

HRS, EHRA and APHRS issue guidelines for diagnosing, treating inherited arrhythmia syndromes... Page 2

Passing of the Gavel

Ceremony installs Hugh Calkins, MD, FHRS, as the 35th President of the Heart Rhythm Society... Page 5

PRESidEnt’S LEttER, continued on Page 4

tRiaLS, continued on Page 11

Hugh Calkins, MD, FHRS, CCDS

Daily HigHligHts

34TH ANNUAL SCIENTIFIC SESSIONS MAY 8–11, 2013 | DENVER, CO

Saturday

Science | Discovery | Innovation

HONORING OUR PAST. SHAPING OUR FUTURE.

www.HRSonline.org/ADV

Vivek Reddy, MD

Saturday

7:30 a.m. – noon

registration Open

8 – 9:30 a.m.

Late-Breaking Clinical Trials Session iii

8 – 9:30 a.m.

Preparing For the eP iBhre exam:

Challenging Cases and Questions

8 – 9:30 a.m.

Preparing For the eP Board exam: Cieds

9:30 a.m. – noon

Poster Session (Lobby d)

10:30 a.m. – noon

Preparing For the device iBhre exam:

Challenging Cases and Questions

10:30 a.m. – noon

Preparing For the eP Board exam:

intracardiac electrograms, arrhythmia

Mechanisms, and Mapping

10:30 a.m. – noon

MOC: Self-evaluation

Process: 2012 Update

in Clinical Cardiac

electrophysiology

Module B3M

Versions 12-1

YOUR AD HERE!

Heart Rhythm 2014 | 4

HIGH VISIBILITY MEANS YOUR COMPANYREACHES THOUSANDS OF ATTENDEES!

MOBILE DAILY BANNER ADThe mobile edition of the Heart Rhythm Daily newspaper features several key articles from each issue of the printed newspaper. Pushed out to members and event attendees, the mobile edition allows readers to comment on articles, connect via social networking tools, forward articles via email, and provides a complete listing of exhibitors. The exclusive sponsor of the mobile edition receives a linking banner at the top of each edition.

Support Fee: $16,950 (includes a full-page, four-color ad to be placed run of book in each issue of the Heart Rhythm Daily)

Special note: The mobile edition is viewable on all Internet-ready smart phones and tablets. Our user-friendly format delivers content in a way that best suits each user’s device capabilities and settings.

Specifications for the Mobile Daily BannerWidth – 280 pixels Height – 50 to 60 pixels (PNG is the recommended image format)

DISTRIBUTION RACK SPONSORSHIP The exclusive sponsor of the Heart Rhythm Daily Distribution Racks is guaranteed incredible visibility each time an attendee passes by or grabs an extra newspaper from one of the five strategically placed newspaper racks in Moscone Center. Place your company logo and/or product advertisement on each of the five distribution racks. This unique marketing opportunity includes advertising on the side panels and front kickplate of the racks, as well as a full-page, four-color ad in each issue of the newspaper.

Support Fee: $16,700

March 21, 2014 – Ad Space/PaymentMarch 28, 2014 – Ad Materials Due

Advertise your

company on

the side panels

and front kickplate

of the distribution

racks!

Heart Rhythm 2014 | 5

GENERAL NOTES1. All advertisements are subject to approval by HRS.2. Circulation is based on projected attendance and room blocks at

the time of rate card printing.3. For inserts in Heart Rhythm Daily, the advertiser is responsible

for sending the correct number of pieces. TriStar will not be responsible for shortages due to an incorrect number of pieces being received.

4. TriStar reserves the right to cancel any publication or service in the event of revenue shortfalls. TriStar shall refund monies paid for participation in the publications or service. TriStar is not obli-gated to offer or replace the canceled publication or service with any other advertising vehicle.

FINANCIAL CONSIDERATIONS1. All signed agreements are firm. No cancellations.2. Payment due upon space commitment. 3. No agency commission or cash discounts permitted. Rate card

prices are NET.4. Fees will apply for noncompliance with the shipping instructions or

failure to fully complete shipping label provided.5. A minimum $500 late fee will be charged for materials received

after the specified due date.6. Due to stringent hotel labor policies, TriStar Publishing is not liable

for a hotel’s failure to deliver to rooms in the designated hotel room block. There will be no discounts or refunds given.

7. TriStar will be diligent in providing the highest quality publications possible. It is understood the print quality of the daily newspapers is subject to the availability of the printer(s) in the event city. TriStar Publishing, Inc., will not provide any refunds or discounts on advertisements in the daily newspaper due to clarity, ink saturation, or any other issues beyond the publisher’s control, when in a city with limited print options.

FILE SUBMISSION SPECIFICATIONSAcceptable file formats• Adobe InDesign CS6• Fonts: Adobe Type 1 or outlined• Images: Must be at least 300 dpi at the desired print size• Adobe Illustrator (fonts outlined) and Adobe Photoshop (flattened

image)• Press/print ready PDF (PDF/X compliant)• All colors must be CMYK

Color proofsColor proofs are necessary for checking color and content at press time. Without a color proof, the publisher cannot be held responsible for the outcome of the color on press.

Submitting files• DVD/CD/Flash drive• FTP: Contact your TriStar representative for login information and

upload instructions.• Email: Files less than 10MB can be emailed to ads@tristarpub.com

with the subject line specifying the publication name and the advertiser name

Unacceptable programs• Corel Draw• Microsoft Publisher• Microsoft Word and Microsoft PowerPoint

Note: Deviation from these guidelines may require additional time and costs, and/or sacrifice reproduction predictability. Publisher cannot be held responsible for problems on press caused by improperly distilled PDF files.

AD SPACE RESERVATIONS Contact your TriStar Event Media Strategist

Melanie Johnsonmjohnson@tristarpub.com

Darcey Tenbrinkdtenbrink@tristarpub.com

Nan Blunknblunk@tristarpub.com

Payment OptionsPayments may be made via check, wire transfer, or credit card.Payments made by credit card shall have an additional fee of 2% added to the total purchase price. This fee can not be waived.

Send payments to:Accounts PayableTriStar Publishing, Inc.7285 W. 132nd Street, Suite 300Overland Park, KS 66213

JB 2.6.14